Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hallinan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|January 10, 2006
Is methadone too dangerous for opiate addiction? Methadone is still needed in addiction treatmentsAndrew Byrne, Richard Hallinan
Australian and New Zealand Journal of Public Health|June 11, 2002
HIV seroconversionAndrew Byrne, Richard Hallinan
Drug and Alcohol Review|January 23, 2003
Administration of a lighter-coloured methadone liquidAndrew Byrne, Richard Hallinan, Anne Love
Drug and Alcohol Review|June 15, 2007
Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reductionRichard Hallinan, Andrew Byrne, Gregory J Dore
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Does electrocardiography improve methadone safety?Andrew Byrne, Richard Hallinan, Robert G Newman
Addiction Biology|September 30, 2005
Naltrexone implants as treatment for heroin dependence: part IAndrew Byrne, Garry Graham, Richard Hallinan, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 12, 2005
Methadone vs buprenorphineAndrew Byrne, Richard Hallinan, Richard Watson, et al.
Drug and Alcohol Dependence|October 28, 2006
Referral for chronic hepatitis C treatment from a drug dependency treatment settingRichard Hallinan, Andrew Byrne, Kingsley Agho, et al.
Journal of Gastroenterology and Hepatology|June 16, 2005
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Australian and New Zealand Journal of Public Health|February 15, 2005
Hepatitis C virus incidence among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|January 10, 2006
Is methadone too dangerous for opiate addiction? Methadone is still needed in addiction treatmentsAndrew Byrne, Richard Hallinan
Australian and New Zealand Journal of Public Health|June 11, 2002
HIV seroconversionAndrew Byrne, Richard Hallinan
Drug and Alcohol Review|January 23, 2003
Administration of a lighter-coloured methadone liquidAndrew Byrne, Richard Hallinan, Anne Love
Drug and Alcohol Review|June 15, 2007
Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reductionRichard Hallinan, Andrew Byrne, Gregory J Dore
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 3, 2010
Does electrocardiography improve methadone safety?Andrew Byrne, Richard Hallinan, Robert G Newman
Addiction Biology|September 30, 2005
Naltrexone implants as treatment for heroin dependence: part IAndrew Byrne, Garry Graham, Richard Hallinan, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 12, 2005
Methadone vs buprenorphineAndrew Byrne, Richard Hallinan, Richard Watson, et al.
Drug and Alcohol Dependence|October 28, 2006
Referral for chronic hepatitis C treatment from a drug dependency treatment settingRichard Hallinan, Andrew Byrne, Kingsley Agho, et al.
Journal of Gastroenterology and Hepatology|June 16, 2005
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Australian and New Zealand Journal of Public Health|February 15, 2005
Hepatitis C virus incidence among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Pageof 2